Analysts have clear opinions on MEDP.

There are 2 analysts on the Wall offering 12 month price targets for Medpace Holdings in the last 3 months. The average price target is $75.50 with a high forecast of $105.00 and a low forecast of $46.00. The average price target represents a 22.35% increase from the last price of $61.71.
Medpace Holdings, Inc. (MEDP) is followed by 2 analysts on the street.

null from rates it a .

Similarly, null of a with a target of .

The consensus on the street is null.

What does Medpace Holdings, Inc.(MEDP) do ?
Medpace Holdings, Inc. is a contract research organization, which engages in the provision of outsourced clinical development services to the biotechnology, pharmaceutical and medical device industries. Its services include medical department, clinical trial management, data-driven feasibility, study-start-up, clinical monitoring, regulatory affairs, patient recruitment and retention, medical writing, biometrics and data sciences, pharmacovigilance, core laboratory, laboratories, clinics, and quality assurance. The company was founded by August James Troendle in July 1992 and is headquartered in Cincinnati, OH.

Medpace Holdings, Inc. (MEDP) Insider Trades

Multiple company employees have indulged in significant insider trading. Medpace Holdings, Inc. disclosed the following in a document filed with the US Securities and Exchange Commission (SEC):

CFO, COO, Lab Operations, Geiger Jesse J : S – Sale(-$2,604,432) of MEDP in the trading session of 2019-12-19.

GC, Corp. Secy. Ewald Stephen P : S – Sale(-$618,400) of MEDP in the trading session of 2019-10-18.

CFO, COO, Lab Operations Geiger Jesse J : S – Sale(-$1,329,816) of Medpace Holdings, Inc. in the trading session of 2019-10-14.

Looking for stocks just like MEDP?

Based on Wall Street analyst research, several stocks are similar to MEDP
They are:
– SYNH [Info can be found here: ]
– IQV [Info can be found here: ]
– PRAH [Info can be found here: ]